Jaime Bartushak
Förmögenhet: 659 931 $ per 2026-05-31
Förmögenhet: 659 931 $ per 2026-05-31
Jaime Bartushak is the founder.
Mr. Bartushak was the Chief Financial Officer at Leonard-Meron Biosciences, Inc. since 2014.
Mr. Bartushak is the CFO, Chief Accounting & Business Officer at Citius Pharmaceuticals, Inc. since 2022.
Mr. Bartushak is the Chief Financial Officer & Treasurer at Citius Oncology, Inc. since 2024.
Education includes undergraduate and graduate degrees from New Jersey Institute of Technology.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
0,89 % | 2025-09-19 | 825 000 ( 0,89 % ) | 658 350 $ | 2026-05-31 |
| 2026-02-13 | 2 414 ( 0,01 % ) | 1 581 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2017-11-27 |
| Företag | Position | Slut |
|---|---|---|
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products | Grundare | 2017-11-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company | Health Technology |
New Jersey Institute of Technology
New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leonard-Meron Biosciences, Inc.
Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån